'Optimized for the underserved': A new diagnostic test built for low-income settings
In this article for Devex, Catherine Cheney reports on a new, portable diagnostic system for sickle cell disease that could serve as a model for developing testing systems for other diseases in low-resource areas.
In the article, the writer examines how Gazelle, a new testing system for sickle cell disease, could impact testing systems for other health burdens including COVID-19.
Medical diagnostic device company Hemex Health is the US-based creator of Gazelle. It has programmed the diagnostic system to also test for malaria. Gazelle is specifically adapted for use in low- and middle-income countries by being affordable, fast, accurate, and easy to use.
In a discussion of Gazelle's potential application for COVID-19 diagnosis, the article quotes the Foundation's Executive Director Jayasree K. Iyer on the need for fair allocation of any resulting products.